Home › Leucemia mieloide acuta › Kansas › Overland Park
Studi clinici su Leucemia mieloide acuta a Overland Park, KS
11 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a Overland Park e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
In reclutamentoFase 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi di distanza
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi di distanza
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- University of Kansas Clinical Research Center, Fairway · a 3 mi di distanza
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi di distanza
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi di distanza
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
In reclutamentoFase 3
- US-Kansas City KS-KUMC, Fairway · a 3 mi di distanza
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
In reclutamentoFase 1
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi di distanza
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
In reclutamentoFase 1
- The University of Kansas Medical Center Research Institute, Fairway · a 3 mi di distanza
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
In reclutamentoFase 1
- University of Kansas, Fairway · a 3 mi di distanza
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
In reclutamentoFase 2
- University of Kansas Cancer Center, Fairway · a 3 mi di distanza
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
In reclutamentoFase 1
- University of Kansas Cancer Center, Fairway · a 3 mi di distanza
Studi su Leucemia mieloide acuta in altre città
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Seattle, WA41 studi
- Baldwin Park, CA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA31 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Altri studi a Overland Park
- Cancro del polmone non a piccole cellule16 studi
- Cancro ai polmoni11 studi
- Cancro al seno10 studi
- Fibrillazione atriale8 studi
- Cancro colorettale8 studi
- Obesità7 studi
- Cancro pancreatico7 studi
- Cancro alla prostata7 studi
- Melanoma6 studi
- Sovrappeso6 studi
- Cancro ovarico6 studi
- Cancro (tutti i tipi)5 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.